Tom Giannulli

Tom Giannulli

Vorstandsvorsitzender bei PatientDirected, Inc.

Technology Services
Consumer Services
Health Technology

Profil

Thomas C.
Giannulli
was the founder of CareTools, Inc. (founded in 2003) where he held the title of Chief Executive Officer in 2009.
He is also the founder of PatientDirected, Inc. (founded in 2018) where he currently holds the titles of CEO, Principal Financial & Accounting Officer.
Dr. Giannulli's former jobs include Chief Executive Officer at HealthScan Products, Inc. from 2001 to 2004, Chief Executive Officer at Physix, Inc., Vice President-Advanced Research at Data Critical Corp., Chief Medical Information Officer at Epocrates LLC, and Chief Medical Information Officer at Kareo, Inc. Dr. Giannulli's education history includes a graduate degree from the University of Utah, a doctorate degree from The University of Texas at Austin, and an undergraduate degree from the University of California, Irvine.
Dr. Giannulli is also the founder of Carepoynt LLC.

Aktive Positionen von Tom Giannulli

UnternehmenPositionBeginn
Vorstandsvorsitzender 01.01.2018
Alle aktiven Positionen von Tom Giannulli

Ehemalige bekannte Positionen von Tom Giannulli

UnternehmenPositionEnde
Vorstandsvorsitzender 01.08.2009
Vorstandsvorsitzender 01.12.2004
Vorstandsvorsitzender -
Technik-/Wissenschafts-/F&E-Leiter -
Technik-/Wissenschafts-/F&E-Leiter -
Sehen Sie sich die Erfahrung von Tom Giannulli im Detail an

Ausbildung von Tom Giannulli

University of Utah Graduate Degree
The University of Texas at Austin Doctorate Degree
University of California, Irvine Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Tom Giannulli im Detail an

Unternehmensverbindungen

Private Unternehmen8

Technology Services

Health Technology

Technology Services

Health Technology

Electronic Technology

Technology Services

Health Services

Technology Services

  1. Börse
  2. Insiders
  3. Tom Giannulli
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT